# Bortezomib

NDC: 70069-836
Generic name: bortezomib
Labeler / Manufacturer: Somerset Therapeutics LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20250429

FDA application: ANDA211898

## Active ingredients

- BORTEZOMIB: 3.5 mg/3.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70069-836"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70069-836
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dc737d3d-2a4e-448a-ad70-e013065c411c